---
title: "COCP Q1'26 Earnings: EPS estimate is (0.15) USD"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286552795.md"
description: "COCP (Cocrystal Pharma, Inc.) is set to announce its Q1'26 results on May 18, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q1'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.15) USD. Learn more details at .Revenue & EPS values are provided in USDQ1'25Q2'25Q3'25Q4'25Q1'26Revenue Reported—————Revenue Estimate—————Revenue SurpriseEPS Reported(0.23)(0.20)(0.19)(0.16) EPS Estimate(0.51)(0.23)(0.21)(0.17)(0.15) EPS Surprise+54.46%+13.04%+11.63%+8.57%DisclaimerSelect reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc."
datetime: "2026-05-15T11:00:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286552795.md)
  - [en](https://longbridge.com/en/news/286552795.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286552795.md)
---

# COCP Q1'26 Earnings: EPS estimate is (0.15) USD

COCP (Cocrystal Pharma, Inc.) is set to announce its Q1'26 results on May 18, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).

For Q1'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.15) USD. Learn more details at .

**Revenue & EPS values are provided in USD**

Q1'25

Q2'25

Q3'25

Q4'25

Q1'26

**Revenue Reported**

—

—

—

—

—

**Revenue Estimate**

—

—

—

—

—

**Revenue Surprise**

**EPS Reported**

(0.23)

(0.20)

(0.19)

(0.16)

**EPS Estimate**

(0.51)

(0.23)

(0.21)

(0.17)

(0.15)

**EPS Surprise**

+54.46%

+13.04%

+11.63%

+8.57%

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.

### Related Stocks

- [COCP.US](https://longbridge.com/en/quote/COCP.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)

## Related News & Research

- [Immix Biopharma Announces 95% Complete Response Rate In Interim Update From Relapsed/Refractory AL Amyloidosis Clinical Trial NEXICART-2](https://longbridge.com/en/news/287200923.md)
- [Wave Life Sciences posts positive RestorAATion-2 data; WVE-006 restores M-AAT, cuts Z-AAT, supports monthly dosing](https://longbridge.com/en/news/286818220.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)
- [Guardant Health Says US FDA Approved Liquid Biopsy Test](https://longbridge.com/en/news/287069625.md)